[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 1, 2009

Proton Pump Inhibitors and the Risk for Clostridium difficile Infection—Reply

JAMA. 2009;302(1):31-32. doi:10.1001/jama.2009.902

In Reply: Dr Famularo and colleagues raise an interesting and relevant point regarding acid antisecretory therapy as a potential risk factor for CDI. Because the patient under discussion was not reported to be on treatment with a PPI or histamine2-receptor antagonist, this topic was excluded from the review.

In several epidemiologic studies, the use of PPIs has been associated with CDI.13 However, a causal relationship has not been established, and many potential confounding variables exist. Proton pump inhibitors are certainly overprescribed. In my institution, for example, PPI use was recorded in 25% of hospital inpatients with CDI in 1998 compared with 74% in 2005 (P < .001).4 For inpatients, an initial appropriate PPI prescription for prophylaxis against gastrointestinal bleeding is often transformed into a prolonged treatment course with no clear indication. Transient dyspepsia or occasional heartburn are inadequate but common indications for ongoing PPI therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×